$STBA

S&T Bancorp (STBA) Q2 2026 Earnings Call Transcript

S&T Bancorp (STBA) reported Q2 2026 net income of $36.6 million, up 22.9% from $31.9 million a year earlier, and diluted EPS of $1.02. Net interest income rose to $90.4 million and NIM expanded to 3.99%. Loans were $8.1 billion, deposits fell in the quarter but grew year to date. Management guided mid-single-digit loan growth and a $58 million expense run rate.

Original reporting
Published Jul 24, 2026, 3:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 24, 2026, 4:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
S&T Bancorp (STBA) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$STBABullishMed
01

Why it matters

Traders can update expectations for 2026 earnings trajectory based on reported NIM expansion, loan growth mix (C&I and commercial construction), deposit-cost outlook, and the planned pace of share repurchases.

02

Market read

The combination of quantified margin expansion, credit stability, and explicit growth/expense guidance is actionable for regional bank positioning, with CRE payoffs and deposit-cost repricing as the main offsets.

03

What to watch

Permanent commercial real estate payoffs are still shrinking the permanent CRE book, and the Durbin Amendment revenue headwind is only quantified for later periods, which may not be fully priced yet.

Relevance 8/10Novelty 7/10Timing: after-hours earnings call transcript for Q2 2026, with 2026 guidance and buyback commentary

Background

This is the Q2 2026 earnings call transcript for S&T Bancorp, covering profitability, balance-sheet mix, credit quality, capital allocation, and 2026 guidance.

Company-level read

Ticker impact

$STBABullishMedium confidence
Context

S&T Bancorp reported Q2 2026 net income of $36.6M, NIM of 3.99%, and guided mid-single-digit loan growth for the rest of 2026.

Expected impact

Likely modest positive bias as investors focus on NIM expansion, loan growth guidance, and reduced brokered deposits, tempered by ongoing permanent CRE headwinds.

Evidence & confidence

The article provides multiple quantified operating metrics (income, NIM, loan/deposit mix, credit costs) plus explicit 2026 guidance and a regulatory fee impact estimate tied to crossing $10B assets.

Market effects

Adds another data point on how small/regional banks are managing funding mix (brokered deposits down, DDA share maintained) and NIM resilience.

Could influence sentiment toward regional commercial banking balance sheets with similar deposit structures and CRE exposure.

Limited direct global linkage; primarily affects US regional bank positioning and rate-sensitive bank trade narratives.

Counterpoint

The NIM expansion may be partly timing-driven (additional day, asset yield improvements) and could fade as deposit costs reprice after Q3.

Key entities

  • S&T Bancorp, Inc.

    Reported Q2 2026 results and provided 2026 guidance on loan growth and expense run rate, plus commentary on funding mix and regulatory fee impacts.

Related articles

$STBAMed

S&T Bancorp (STBA) Q3 2026 Earnings Call Transcript

S&T Bancorp (STBA) reported Q3 2026 earnings with net interest margin expanding to 4.06% and revenue growth outpacing expense growth. Loan balances were flat, but average loan and deposit balances increased. Tangible book value per share rose to $29.28. The company maintained strong asset quality and expects continued margin expansion with potential rate increases. They plan to upgrade their mobile banking platform in Q4 and anticipate flat to low single-digit loan growth.

$STBAMed

S&T Bancorp Q3 Earnings Call Highlights

S&T Bancorp reported Q3 2026 with revenue growth outpacing expenses, improving efficiency ratio to 54.65%. Loan growth was modest, with commercial real estate up $65M but commercial and industrial down $50M. Deposits saw seasonal decline, but asset quality remained strong. The company paused share buybacks and expects low-single-digit asset growth. Management emphasized underwriting discipline and inorganic growth opportunities.

$STBAMed

S&T Bancorp (STBA) stock is up, what you need to know

S&T Bancorp (STBA) shares rose 4.1% after reporting Q3 2026 earnings of $1.09 per share, beating estimates. Revenue was $107.79M, up from $106.72M expected. Net income increased to $38.6M. The company cited higher loan yields and share buybacks as contributors to the growth. CEO Chris McComish highlighted record earnings and revenue. Shares traded at $51, near the 52-week high of $53.36.

$STBAMed

S&T Bancorp’s (NASDAQ:STBA) Q3 2026 sales beat estimates

S&T Bancorp (STBA) reported Q3 2026 sales exceeding estimates, with net interest income comprising 87.6% of total revenue over five years. TBVPS grew at 7% annually over five years but slowed to 5.9% recently. EPS beat expectations, while net interest income narrowly outperformed estimates. TBVPS slightly missed forecasts. The stock price remained unchanged at $48.86 post-results.